Stereotactic radiosurgery for type 2 neurofibromatosis acoustic neuromas: Patient selection and tumour size

被引:26
|
作者
Rowe, JG [1 ]
Radatz, M [1 ]
Walton, L [1 ]
Kemeny, AA [1 ]
机构
[1] Royal Hallamshire Hosp, Dept Stereotact Radiosurg, Natl Ctr Stereotact Radiosurg, Sheffield S10 2JF, S Yorkshire, England
关键词
stereotactic radiosurgery; neurofibromatosis; acoustic neuroma;
D O I
10.1159/000070106
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acoustic neuromas which are secondary to type 2 neurofibromatosis (NF2) respond less well to radiosurgery than unilateral sporadic disease. To refine the selection of these patients, a regression analysis was performed examining the response to radiosurgery of 114 NF2 tumours. The major determinant of outcome was tumour volume (p < 0.001). Calculating sensitivity and specificity values for different tumour volume limits gives a sensitivity value of 0.96 for a volume limit of 10 cm(3). This suggests that the size constraints that apply to the radiosurgical management of NF2 acoustic neuromas differ and are more restricted than those which are accepted for acoustic neuromas in general. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 50 条
  • [21] Geometric accuracy of MRI for stereotactic radiosurgery planning of Acoustic Neuromas at 3 Tesla
    Schmidt, M. A.
    Wells, E.
    Davison, K.
    Riddell, A.
    Welsh, L.
    Saran, F.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S899 - S900
  • [22] Frameless Hypofractionated Stereotactic Radiosurgery for Acoustic Neuromas: A Single-Institution Experience
    Huang, C. I.
    Yang, C. C.
    Lin, Y. W.
    Kuo, T. Y.
    Lin, L. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E62 - E62
  • [23] Stereotactic radiosurgery for acoustic neuromas: A survey of the American Neurotology Society - Invited comments
    Sekhar, LN
    Chandrasekar, K
    AMERICAN JOURNAL OF OTOLOGY, 2000, 21 (03): : 377 - 377
  • [24] Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas
    Combs, SE
    Thilmann, C
    Debus, J
    Schulz-Ertner, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (05): : 1341 - 1347
  • [25] Impact of tissue heterogeneity correction on Gamma Knife stereotactic radiosurgery of acoustic neuromas
    Peters, Gabrielle W.
    Tien, Christopher J.
    Chiang, Veronica
    Yu, James
    Hansen, James E.
    Aneja, Sanjay
    JOURNAL OF RADIOSURGERY AND SBRT, 2020, 7 (03): : 207 - 212
  • [26] Fractionated Stereotactic Radiotherapy Compared to Stereotactic Radiosurgery for Vestibular Schwannoma in Patients with Type 2 Neurofibromatosis
    Mauro, Geovanne Pedro
    Da Roz, Leila Maria
    Gico, Vinicius de Carvalho
    Weltman, Eduardo
    de Souza, Evandro Cesar
    Figueiredo, Eberval Gadelha
    Teixeira, Manoel Jacobsen
    WORLD NEUROSURGERY, 2023, 179 : E416 - E420
  • [27] Radiosurgery and stereotactic radiation therapy for vestibular schwannoma in neurofibromatosis type 2 patients
    Meijer, OW
    Vandertop, WP
    Lagerwaard, FJ
    Slotman, BJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S407 - S407
  • [28] Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas)
    Welling, DB
    LARYNGOSCOPE, 1998, 108 (02): : 178 - 189
  • [29] Radiotherapeutic management of acoustic neuromas single fraction radiosurgery versus fractionated stereotactic radiotherapy
    Combs, S. E.
    Volk, S.
    Thilmann, C.
    Huber, P. E.
    Debus, J.
    Schulz-Ertner, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 23 - 23
  • [30] Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas
    Gevaert, Thierry
    Levivier, Marc
    Lacornerie, Thomas
    Verellen, Dirk
    Engels, Benedikt
    Reynaert, Nick
    Tournel, Koen
    Duchateau, Michael
    Reynders, Truus
    Depuydt, Tom
    Collen, Christine
    Lartigau, Eric
    De Ridder, Mark
    RADIOTHERAPY AND ONCOLOGY, 2013, 106 (02) : 192 - 197